Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?

Novel drugs have improved survival for patients with multiple myeloma in recent years. However, the disease is still fatal. Allogeneic stem cell transplantation (Allo) has proven to cure some patients with the disease, but its role is controversial due to relatively high transplant-related toxicity...

Full description

Bibliographic Details
Main Authors: Gösta Gahrton, Simona Iacobelli, Laurent Garderet, Ibrahim Yakoub-Agha, Stefan Schönland
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
allogeneic transplantation
multiple myeloma
Online Access:https://www.mdpi.com/2077-0383/9/7/2180

Similar Items

Similar Items